candesartan has been researched along with prednisolone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kawakami, K; Komiya, T; Negoro, N; Okada, S; Okamura, M; Okazaki, M; Sumi, T; Tsukamoto, J; Yoshikawa, J | 1 |
| Koide, Y; Sakai, M; Sakurai, Y; Tamura, K; Tokita, Y; Toya, Y; Tsurumi, Y; Umemura, M; Umemura, S; Usui, T; Yabana, M; Yano, H | 1 |
| Bae, YI; Lee, JB; Lee, SC; Park, GT; Yun, SJ | 1 |
| Katayama, A; Makino, H; Matsumoto, Y; Nasu, Y; Otsuka, F; Tanabe, K; Tsukamoto, N; Yamanaka, R | 1 |
1 review(s) available for candesartan and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for candesartan and prednisolone
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis].
Topics: Adult; Angiotensin Receptor Antagonists; Anticoagulants; Antigen-Antibody Complex; Antihypertensive Agents; Antiphospholipid Syndrome; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Tetrazoles; Treatment Outcome | 2002 |
Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biopsy; Biphenyl Compounds; Blood Component Removal; C-Reactive Protein; Coronary Angiography; Creatinine; Crystallization; Embolism, Cholesterol; Eosinophils; Humans; Kidney; Leukocyte Count; Lipoproteins, LDL; Male; Prednisolone; Proteinuria; Renal Dialysis; Skin; Tetrazoles | 2003 |
Pemphigus foliaceus induced by an angiotensin II receptor blocker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Female; Humans; Hypertension; Immunosuppressive Agents; Pemphigus; Prednisolone; Telmisartan; Tetrazoles | 2008 |
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Nifedipine; Prednisolone; Ribonucleosides; Spironolactone; Tetrazoles | 2011 |